NAS:CNCR

Range Cancer Therapeutics ETF

$ 16.11 0.6582 ( +4.26%) 03:59 PM EST
PE Ratio:
32.96
PB Ratio:
1.89
Volume:
6.74K
Dividend Yield %:
0
Last Holding update 2024-07-30 77 Stocks (0 new)
Value $17.00 Mil Turnover 23 %
Portfolio Report
Registrant: Range Cancer Therapeutics ETF
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
This section is for PremiumPlus GuruFocus PremiumPlus Icon Membership subscribers only.
GuruFocus PremiumPlus GuruFocus PremiumPlus Icon Membership
  Backtesting
  13F, 13D/G of all institutional investors
  Aggregated portfolio of any combinations among them
  FilingWiz
  Excel Add-In unlimited queries
  API (20,000 queries/month)

Discussions on Range Cancer Therapeutics ETF

User's Avatar
How would you rate this stock? CNCR
No discussions yet.